Skip to main content
S 2640 117th Congress Senate Health Child health Drug therapy Health care coverage and access Health programs administration and funding Immunology and vaccination Infectious and parasitic diseases Manufacturing Medical research Medical tests and diagnostic methods Military medicine Military personnel and dependents Public contracts and procurement Research administration and funding Research and development Small business

Disease X Act

Introduced: August 5, 2021 Introduced by: Baldwin, Tammy Democratic · Wisconsin See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Aug 5, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Disease X Act

This bill establishes a program to develop vaccines, diagnostics, and other medical countermeasures for unknown viral threats.

Specifically, the Biomedical Advanced Research and Development Authority must carry out the program in consultation with the Public Health Emergency Medical Countermeasure Enterprise, which coordinates efforts related to medical countermeasures within the Department of Health and Human Services (HHS) and in cooperation with interagency partners. Additionally, the program must prioritize equity and accessibility in the development of the medical countermeasures.

The bill also allows HHS to support domestic research, development, and manufacturing of medical countermeasures under the program through grants, contracts, and cooperative agreements.

What's happening now August 5, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1 Independent 1
I
King, Angus S., Jr.
Maine · Aug 5, 2021
 D
Smith, Tina
Minnesota · Aug 5, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2640: Disease X Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-2640/
MLA
"S. 2640: Disease X Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2640/.
Bluebook (legal)
S. 2640, 117th Cong. (2026), https://openamerica.io/bill/117-S-2640/.
Markdown link
[S. 2640: Disease X Act](https://openamerica.io/bill/117-S-2640/)
Report a problem